Oligometastatic Non-small Cell Lung Cancer (NSCLC)
2 clinical trials · Condition
◉ Watch Oligometastatic Non-small Cell Lung Cancer (NSCLC)
| Record | Firm | Date |
|---|---|---|
| Phase II Study of Pembrolizumab After Curative Intent Treatment for Oligometastatic Non-Small Cell Lung Cancer (NCT02316002) | Abramson Cancer Center at Penn Medicine | 2015-01-21 |
Track Oligometastatic Non-small Cell Lung Cancer (NSCLC) automatically
Every clearance here is in the API, with alerts when new ones post.